Claus Juan Møller-San Pedro

Direktor/Vorstandsmitglied bei Terranol A/S

62 Jahre

Health Technology

Consumer Services

Commercial Services

Aktive Beziehungen

Name	Geschlecht	Alter	Unternehmensverbindungen	Zusammenarbeit
Bo Kruse	M	52	GENMAB A/S Y-MABS THERAPEUTICS, INC. Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	24 Jahre
Jan van de Winkel	M	63	GENMAB A/S	25 Jahre
James Healy	M	59	Y-MABS THERAPEUTICS, INC.	7 Jahre
Ole Sibbesen	M	-	Terranol A/S Terranol A/S Miscellaneous Commercial ServicesCommercial Services Terranol A/S develops yeasts to be applied in second generation bioethanol production. Its second generation bioethanol is produced from agricultural wastes, such as wheat straw, sugar cane bagasse, corn stover, and wood chips. It has developed industrial yeasts that converts all sugars and also the sugar xylose in biomass into ethanol. The company's technology Terranol Strain V-1 ferments glucose and xylose into ethanol with high yield and low production of the byproduct xylitol. Terranol was founded by Thomas Hvid Andersen, Birgitte Rønnow, and Ole Sibbesen in October 2007 and is headquartered in Kongens Lyngby, Denmark.	17 Jahre
Thomas Hvid Andersen	M	-	Terranol A/S Terranol A/S Miscellaneous Commercial ServicesCommercial Services Terranol A/S develops yeasts to be applied in second generation bioethanol production. Its second generation bioethanol is produced from agricultural wastes, such as wheat straw, sugar cane bagasse, corn stover, and wood chips. It has developed industrial yeasts that converts all sugars and also the sugar xylose in biomass into ethanol. The company's technology Terranol Strain V-1 ferments glucose and xylose into ethanol with high yield and low production of the byproduct xylitol. Terranol was founded by Thomas Hvid Andersen, Birgitte Rønnow, and Ole Sibbesen in October 2007 and is headquartered in Kongens Lyngby, Denmark.	17 Jahre
David Gill	M	69	Y-MABS THERAPEUTICS, INC.	7 Jahre
Anthony Pagano	M	46	GENMAB A/S	17 Jahre
Ashutosh Tyagi	M	47	Y-MABS THERAPEUTICS, INC.	7 Jahre
Birgitte Rønnow	M	-	Terranol A/S Terranol A/S Miscellaneous Commercial ServicesCommercial Services Terranol A/S develops yeasts to be applied in second generation bioethanol production. Its second generation bioethanol is produced from agricultural wastes, such as wheat straw, sugar cane bagasse, corn stover, and wood chips. It has developed industrial yeasts that converts all sugars and also the sugar xylose in biomass into ethanol. The company's technology Terranol Strain V-1 ferments glucose and xylose into ethanol with high yield and low production of the byproduct xylitol. Terranol was founded by Thomas Hvid Andersen, Birgitte Rønnow, and Ole Sibbesen in October 2007 and is headquartered in Kongens Lyngby, Denmark.	17 Jahre
Johan Ernst Wedell-Wedellsborg	M	54	Y-MABS THERAPEUTICS, INC.	9 Jahre
Laura Hamill	F	60	Y-MABS THERAPEUTICS, INC.	4 Jahre
Gérard Ber	M	66	Y-MABS THERAPEUTICS, INC.	6 Jahre
Joris Wilms	M	50	Y-MABS THERAPEUTICS, INC.	8 Jahre
Martine van Vugt	M	71	GENMAB A/S	23 Jahre
Vignesh Rajah	M	59	Y-MABS THERAPEUTICS, INC.	4 Jahre
Torben Lund-Hansen	M	73	Y-MABS THERAPEUTICS, INC.	8 Jahre
Michael Frank	M	61	Terranol A/S Terranol A/S Miscellaneous Commercial ServicesCommercial Services Terranol A/S develops yeasts to be applied in second generation bioethanol production. Its second generation bioethanol is produced from agricultural wastes, such as wheat straw, sugar cane bagasse, corn stover, and wood chips. It has developed industrial yeasts that converts all sugars and also the sugar xylose in biomass into ethanol. The company's technology Terranol Strain V-1 ferments glucose and xylose into ethanol with high yield and low production of the byproduct xylitol. Terranol was founded by Thomas Hvid Andersen, Birgitte Rønnow, and Ole Sibbesen in October 2007 and is headquartered in Kongens Lyngby, Denmark.	-
Niels Mazanti	M	62	Terranol A/S Terranol A/S Miscellaneous Commercial ServicesCommercial Services Terranol A/S develops yeasts to be applied in second generation bioethanol production. Its second generation bioethanol is produced from agricultural wastes, such as wheat straw, sugar cane bagasse, corn stover, and wood chips. It has developed industrial yeasts that converts all sugars and also the sugar xylose in biomass into ethanol. The company's technology Terranol Strain V-1 ferments glucose and xylose into ethanol with high yield and low production of the byproduct xylitol. Terranol was founded by Thomas Hvid Andersen, Birgitte Rønnow, and Ole Sibbesen in October 2007 and is headquartered in Kongens Lyngby, Denmark.	-
Birgitte Stephensen	F	63	GENMAB A/S	22 Jahre
Anders Gersel Pedersen	M	73	GENMAB A/S	21 Jahre
Sue Smith	F	54	Y-MABS THERAPEUTICS, INC.	2 Jahre

Mehr sehen

Beziehungs-Chart

Beziehungen zu mehreren Unternehmen

Ehemalige Beziehungen

Name	Geschlecht	Alter	Unternehmensverbindungen	Zusammenarbeit
Hanne Damgaard Jensen	F	-	GENMAB A/S Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	17 Jahre
Michael Blair Widmer	M	76	GENMAB A/S	11 Jahre
Tom Vink	M	61	GENMAB A/S	-
Daniel John Bruno	M	45	GENMAB A/S	5 Jahre
Michael K. Bauer	M	60	GENMAB A/S	14 Jahre
Michael Buschle	M	64	Y-MABS THERAPEUTICS, INC.	1 Jahre
Jan Andersen	M	-	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	-
Ole Baadsgaard	M	72	GENMAB A/S	-
Christina Hahner	F	-	GENMAB A/S	-
Nedjad Losic	M	54	GENMAB A/S	-
Hans Henrik Munch-Jensen	M	64	GENMAB A/S	8 Jahre
Steen Lisby	M	60	Y-MABS THERAPEUTICS, INC. GENMAB A/S	16 Jahre
Karsten Havkrog Pedersen	M	74	GENMAB A/S	11 Jahre
Burt Malkiel	M	90	GENMAB A/S	11 Jahre
Lisa N. Drakeman	M	70	GENMAB A/S	11 Jahre
Jorgen Petersen	M	-	GENMAB A/S	-
Patrick van Berkel	M	55	GENMAB A/S	9 Jahre
Jens Munch-Hansen	M	69	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	9 Jahre
Per Gullestrup	M	-	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	9 Jahre
Rikke Glahn Ren	F	-	GENMAB A/S	-
Irwin Lerner	M	93	GENMAB A/S	-
Donald Lee Drakeman	M	70	GENMAB A/S	-
Paul W. H. I. Parren	M	60	GENMAB A/S	16 Jahre
Annarie Lyles	M	63	GENMAB A/S	-
Joseph Fred Yospe	M	66	GENMAB A/S	2 Jahre
Michael Wolff Jensen	M	53	GENMAB A/S	3 Jahre
Greg Raskin	M	51	Y-MABS THERAPEUTICS, INC.	5 Jahre
Florian Schönharting	M	55	GENMAB A/S	-
Peter James Arthur Benson	M	69	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	2 Jahre
Philip Herman	M	-	Y-MABS THERAPEUTICS, INC.	3 Jahre

Statistik

Land	Beziehungen	% des Gesamten
Dänemark	38	74,51%
Vereinigte Staaten	15	29,41%

Alter der Beziehungen

Aktive

Vergangene

Herr

Frau

Aufsichtsräte

Führungskräfte

Ursprung der Beziehungen